STREPIMMUNE Trademark
Trademark Overview
On Wednesday, July 8, 1998, a trademark application was filed for STREPIMMUNE with the United States Patent and Trademark Office. The USPTO has given the STREPIMMUNE trademark a serial number of 75515162. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 27, 1999. This trademark is owned by Siga Pharmaceuticals, Inc.. The STREPIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines
General Information
Serial Number | 75515162 |
Word Mark | STREPIMMUNE |
Filing Date | Wednesday, July 8, 1998 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, October 27, 1999 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Vaccines |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 7, 1998 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Siga Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Trademark Events
Event Date | Event Description |
Wednesday, October 27, 1999 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, October 27, 1999 | ASSIGNED TO EXAMINER |
Wednesday, March 24, 1999 | NON-FINAL ACTION MAILED |
Wednesday, March 10, 1999 | ASSIGNED TO EXAMINER |